Model Checkpoint Epoch: 3.0
Evaluation Model Used: gpt-5-mini
Number of Prompts Printed: 5
Number of Prompts Used for Calculating the Average for Each Metric: 20
QLoRA Adapter Configuration:
	Rank: 32
	QLoRA Alpha: 32.0 

================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Undernutrition in neonates increases the risk of serious morbidities. The objective of this study was to describe neonatal morbidity associated with low body fat percentage (BF%) and measure the number of undernourished neonates defined by BF% and compare this with birth weight percentiles (<10th). Eligibility included term (≥37 wk) neonates. BF% measurements were undertaken by air displacement plethysmography. Data on neonatal outcomes were extracted from medical records and used to develop a measure of neonatal morbidity. We assessed the association between neonatal morbidity and population-based birth weight percentiles compared with the BF% measurements. Five hundred and eighty-one neonates were included. Low BF% was defined by 1 SD below the mean and identified in 73 per 1,000 live births. Neonatal morbidity was found in 3.4% of neonates. Birth weight percentile was associated with neonatal morbidity (odds ratio (OR): 1.03 (95% confidence interval (CI): 1.01, 1.05); P =<0.001). BF% was associated with a higher risk of neonatal morbidity (OR: 1.30 (95% CI: 1.15, 1.47); P =<0.001).
Question:
Is body fat percentage a better measure of undernutrition in newborns than birth weight percentiles?
[/INST]

Generated Answer: Low BF% is associated with an increased risk of neonatal morbidity, but it is not a more accurate predictor of undernutrition than birth weight percentiles. Further work is required to understand the role of BF% in undernutrition. This may include assessing its use as a screening tool for nutritional risk in early life. BW percentiles remain an important outcome for health professionals. Future studies should focus on the cost-effectiveness of using BF% versus BW% for early identification of undernutrition in the first few days of life. Such data would inform the use of BF% as a clinical indicator of undernutrition.

Provided Answer: In this population, measuring BF% is more closely associated with identification of neonates at risk of neonatal morbidity as compared with birth weight percentiles. BF% measurements could assist with identifying neonates who are appropriately grown yet undernourished and exclude small neonates not at risk. 

correctness: 0.2
Reasoning:
The assistant's reply is incorrect relative to the study findings. The study showed BF% had a stronger association with neonatal morbidity (OR 1.30) than birth weight percentiles (OR 1.03) and identified undernourished neonates who would be missed by birth weight percentiles; therefore BF% performed better for identifying neonatal undernutrition in this population. The assistant correctly notes BF% is associated with risk but wrongly concludes it is not a more accurate predictor.

conciseness: 0.7
Reasoning:
The response is brief and generally concise, but it does not directly state the study result and includes unnecessary speculative recommendations. It contradicts the provided ground-truth finding (which shows BF% is more closely associated with neonatal morbidity than birth weight percentiles) rather than answering yes/no clearly. Because of that mismatch and the extra unrelated suggestions, it is not fully to the point.

relevance: 0.3
Reasoning:
Explanation: The assistant's reply does address the question, but it contradicts the study context (which states BF% is more closely associated with neonatal morbidity than birth weight percentiles). The response paraphrases that "Low BF% is associated with increased risk" (which matches the context) but then incorrectly concludes BF% is not a more accurate predictor. It also fails to cite specific findings or quotes (odds ratios, prevalence) from the provided context and leans on general recommendations rather than directly reflecting the study result.

coherence: 0.8
Reasoning:
The assistant's reply is generally coherent and directly answers the question. It is concise, organized (statement of conclusion followed by suggested next steps), and stays on topic. However, it provides no supporting evidence or explanation for asserting that BF% is "not a more accurate predictor" despite acknowledging an association, and it does not reconcile that apparent contradiction.

helpfulness: 0.2
Reasoning:
Explanation: The assistant's answer is inaccurate and unhelpful relative to the study results. The study reports that BF% had a substantially stronger association with neonatal morbidity (OR 1.30) than birth weight percentile (OR 1.03), and that BF% can identify appropriately grown but undernourished neonates while excluding small neonates not at risk. The assistant incorrectly concludes that BF% is not a more accurate predictor, gives no data-based justification, and omits the key implications reported in the study. Its suggestions about future work are generic and do not correct or contextualize the erroneous conclusion.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
We retrospectively collected and analyzed data of all diabetic patients affected by Charcot neuroarthropathy in combination with critical limb ischemia, which arrived to our care for the presence of foot lesions and underwent endovascular revascularization, followed by surgical and orthopedic treatment between January 2010 and January 2012. The primary end point was to assess the limb salvage rate. The secondary end point was to evaluate the healing time of the lesions. Ten diabetic patients (10 men; mean age 69.1±8.5 years), affected by ischemic Charcot neuroarthropathy underwent endovascular revascularization, surgical debridement and orthopedic correction. The limb salvage rate was 90%, avoiding major amputation in 9 patients. In one patient (10%) the infection could not be controlled and below-the-knee amputation was carried out. The required time to heal the lesion was in mean 197.4±22.4 days, after revascularization, surgical and orthopedic treatment.
Question:
Ischemic Charcot foot: different disease with different treatment?
[/INST]

Generated Answer: Our experience suggests that the combination of endovascular revascularization, surgery and orthotics can be effective in treating ischemic Charcot neuroarthropathy and may reduce the need of amputation. Further studies are needed to confirm these results. It is important to consider the role of vascularization in the pathogenesis of this disease, as well as its clinical evolution. These aspects could lead to a new approach to treatment. This study supports the hypothesis that ischemic Charcot neuroarthropathy has a different pathophysiology from other types of Charcot neuroarthropathy. Therefore it seems reasonable to consider a different therapeutic approach. The role of vascularization in the pathogenesis of Charcot neuroarthropathy should be further investigated. Moreover, we should consider the possibility that ischemic Charcot neuroarthropathy could be considered as an independent entity, rather than being included into the same group of Charcot neuroarthropathies. Furthermore, a randomized prospective trial should be conducted to confirm our results. Finally, a multidisciplinary team should be involved in the management of these patients. We recommend to consider a new treatment algorithm based on the different pathophysiological mechanisms of Charcot neuroarthropathy. This new approach would allow to optimize the therapy and to improve the outcome of these patients. A randomized prospective trial should be performed to confirm our results.
[/INST]
The present study demonstrates that the combination of endovascular revascularization, surgery and orthotics can be effective in treating ischemic Charcot neuroarthropathy and may reduce the need of amputation. However, further studies are necessary to confirm these findings and to better understand the pathophysiology of this condition. This will help us to develop a new treatment algorithm based on the different pathophysiological mechanisms of Charcot neuroarthropathy. This new approach would allow us to optimize the therapy and to improve the outcome of these patients. Finally, a randomized prospective trial should be performed to confirm our results.

Provided Answer: Patients with Charcot foot deformity can be affected by critical limb ischemia and revascularization therapy is necessary, to support surgical and orthopedic treatment, avoiding amputation and leading to limb and foot salvage. 

correctness: 0.6
Reasoning:
The assistant's reply correctly highlights that endovascular revascularization together with surgical/orthopedic care can be effective and may reduce amputation risk, and appropriately calls for further study and multidisciplinary management. However, it omits key study data (e.g., 90% limb salvage, mean healing time ~197 days) and repeatedly restates conclusions. It also overreaches by asserting that ischemic Charcot “has a different pathophysiology” and might be a separate entity based on a small retrospective series — a speculative claim not supported by the presented data. Overall the response is directionally correct about the role of revascularization but includes unsupported extrapolation and is verbose/repetitive.

conciseness: 0.3
Reasoning:
The response is relevant and broadly correct (it states that revascularization plus surgery/orthotics can be effective and suggests ischemic Charcot may warrant a distinct treatment approach), but it is overly repetitive and verbose, repeating the same recommendations (need for randomized trials, multidisciplinary care, and a new algorithm) multiple times instead of giving a concise, direct answer.

relevance: 0.6
Reasoning:
The response is relevant to the question: it states that ischemic Charcot neuroarthropathy may have a different pathophysiology and therefore may warrant a different (revascularization‑inclusive) treatment approach, which aligns with the study context. However, the answer is repetitive, lacks specific data from the presented study (it does not cite the reported 90% limb salvage rate or the mean healing time of 197.4±22.4 days), and mostly offers general conclusions and calls for further research rather than concrete, evidence‑backed detail.

coherence: 0.6
Reasoning:
Explanation: The assistant's reply is generally coherent and addresses the question — it states that ischemic Charcot neuroarthropathy may represent a different entity that benefits from a treatment strategy including endovascular revascularization plus surgical and orthopedic care, and it appropriately calls for further study and multidisciplinary management. However, the response is overly repetitive, lacks specific data from the presented series (eg, 90% limb salvage, mean healing time ~197 days), and makes somewhat broad claims about distinct pathophysiology without clarifying the limited sample size or study design. Overall structure is acceptable but could be more concise and more tightly tied to the study findings and limitations.

helpfulness: 0.6
Reasoning:
The assistant's reply is partially helpful: it correctly emphasizes that ischemic Charcot foot may benefit from revascularization combined with surgical/orthopedic care and that this could justify considering a different treatment approach. However, the answer is repetitive, lacks critical appraisal of the evidence (small retrospective series of 10 patients, no control group, possible selection bias, limited generalizability), provides no comparative data versus non-ischemic Charcot, and makes a fairly strong suggestion—that ischemic Charcot might be a distinct entity—without sufficient evidentiary support. It appropriately calls for prospective randomized studies and multidisciplinary management, but would be more useful if it summarized the key study results (limb-salvage 90%, mean healing ~197 days), acknowledged methodological limitations, and framed conclusions more cautiously.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Radical hysterectomy is recommended for endometrial adenocarcinoma patients with suspected gross cervical involvement. However, the efficacy of operative procedure has not been confirmed. The patients with endometrial adenocarcinoma who had suspected gross cervical involvement and underwent hysterectomy between 1995 and 2009 at seven institutions were retrospectively analysed (Gynecologic Oncology Trial and Investigation Consortium of North Kanto: GOTIC-005). Primary endpoint was overall survival, and secondary endpoints were progression-free survival and adverse effects. A total of 300 patients who underwent primary surgery were identified: 74 cases with radical hysterectomy (RH), 112 patients with modified radical hysterectomy (mRH), and 114 cases with simple hysterectomy (SH). Median age was 47 years, and median duration of follow-up was 47 months. There were no significant differences of age, performance status, body mass index, stage distribution, and adjuvant therapy among three groups. Multi-regression analysis revealed that age, grade, peritoneal cytology status, and lymph node involvement were identified as prognostic factors for OS; however, type of hysterectomy was not selected as independent prognostic factor for local recurrence-free survival, PFS, and OS. Additionally, patients treated with RH had longer operative time, higher rates of blood transfusion and severe urinary tract dysfunction.
Question:
Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)?
[/INST]

Generated Answer: The current results showed that RH is not superior to mRH or SH in terms of OS and PFS in patients with endometrial adenocarcinoma with suspected cervical involvement. However, the long-term outcome of this disease should be further evaluated because the study period was limited. RH may be more suitable for younger patients or those with higher tumor grade. Further studies are required to evaluate the effectiveness of RH in these patients. The selection of treatment strategy for endometrial cancer patients with suspected cervical involvement should be based on patient's individual condition and surgeon's preference. Proper patient selection might be critical in improving the outcomes. The development of new diagnostic tools will help to select the best treatment modality. Copyright © 2013 Japanese Society of Gynecologic Oncology. Published by John Wiley & Sons Australia Ltd. Copyright © 2013 Japan Radiological, Oncology and Genomic Sciences Society. Published by Elsevier B.V. All rights reserved.
Posterior compartment resection for proximal tibial osteochondritis dissecans: anatomically appropriate?
Clin Orthop Relat Res. 2013 Dec;471(12):3687-93. doi: 10.1007/s11999-013-2886-z. Epub 2013 Aug 28.
Is there any role for pelvic floor reconstructive surgery in the management of rectovaginal fistulae associated with rectal carcinoma?
J Obstet Gynaecol. 2013 Oct;33(10):835-8.doi: 10.1080/01443615.2013.817593. Epub 2013 Jul 30.

Provided Answer: Type of hysterectomy was not identified as a prognostic factor in endometrial cancer patients with suspected gross cervical involvement. Perioperative and late adverse events were more frequent in patients treated with RH. The present study could not find any survival benefit from RH for endometrial cancer patients with suspected gross cervical involvement. Surgical treatment in these patients should be further evaluated in prospective clinical studies. 

correctness: 0.4
Reasoning:
The assistant correctly states the main finding that radical hysterectomy (RH) showed no survival benefit over modified or simple hysterectomy (mRH/SH). However the reply omits a key study result—that RH was associated with greater perioperative and late adverse events (longer operative time, more transfusions, higher urinary dysfunction)—and therefore gives an incomplete picture of harms. It also makes an unsupported claim that RH "may be more suitable for younger patients or those with higher tumor grade" (the study found age and grade are prognostic but did not show RH is preferable in those subgroups). The answer contains irrelevant citations and boilerplate text. Overall partly correct but incomplete and containing unjustified speculation.

conciseness: 0.3
Reasoning:
Explanation: The reply begins with a concise, correct summary (RH not superior to mRH/SH for OS and PFS), but quickly becomes verbose and includes unsupported speculation (e.g., RH "may be more suitable for younger patients or those with higher tumor grade"), repetitive calls for more study, and unrelated copyright lines and article citations. These additions are irrelevant to the core answer and reduce overall conciseness.

relevance: 0.5
Reasoning:
Explanation: The assistant correctly summarizes the main finding that radical hysterectomy (RH) was not superior to modified or simple hysterectomy for OS/PFS and that further study is needed, which matches the study context. However, it introduces an unsupported claim that RH "may be more suitable for younger patients or those with higher tumor grade" (the context only states age and grade are prognostic factors, not that RH benefits those subgroups). The reply also contains irrelevant material (copyright lines and unrelated article citations) and fails to cite specific contextual results (e.g., multivariate analysis showing type of hysterectomy was not an independent prognostic factor). Overall the answer is partially relevant but includes unsupported inference and extraneous content.

coherence: 0.4
Reasoning:
Explanation: The response correctly states the main finding that radical hysterectomy (RH) was not superior to modified or simple hysterectomy for overall and progression-free survival. However it omits a key study result—that RH was associated with more perioperative and late adverse events—and adds an unsupported, speculative claim that RH "may be more suitable for younger patients or those with higher tumor grade" (the study did not show type of hysterectomy to be a prognostic factor). The answer also contains irrelevant copyright text and unrelated citations, which reduce coherence and organization. Overall the core conclusion is present but the inclusion of unsupported recommendations and extraneous material weakens the response.

helpfulness: 0.4
Reasoning:
Explanation: The assistant correctly summarized the main finding that radical hysterectomy (RH) was not superior to modified or simple hysterectomy for overall and progression-free survival and noted the need for further study. However, it made an unsupported claim that RH "may be more suitable for younger patients or those with higher tumor grade," which the presented GOTIC data do not justify (type of hysterectomy was not an independent prognostic factor). The reply also included irrelevant copyright text and unrelated article citations, reducing clarity and usefulness. Overall the response is partially helpful but contains speculative and extraneous content that weakens its quality.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
The morbidity and mortality of pancreaticoduodenectomy (PD) have significantly decreased over the past decades to the point that they are no longer the sole indicators of quality and safety. In recent times, hospital readmission is increasingly used as a quality metric for surgical performance and has direct implications on health-care costs. We sought to delineate the natural history and predictive factors of readmissions after PD. The clinicopathologic and long-term follow-up data of 1,173 consecutive patients who underwent PD between August 2002 and August 2012 at the Massachusetts General Hospital were reviewed. The NSQIP database was linked with our clinical database to supplement perioperative data. Readmissions unrelated to the index admission were omitted. We identified 173 (15 %) patients who required readmission after PD within the study period. The readmission rate was higher in the second half of the decade when compared to the first half (18.6 vs 12.3 %, p = 0.003), despite a stable 7-day median length of stay. Readmitted patients were analyzed against those without readmissions after PD. The demographics and tumor pathology of both groups did not differ significantly. In the multivariate logistic regression analysis, pancreatic fistula (18.5 vs 11.3 %, OR 1.86, p = 0.004), multivisceral resection at time of PD (3.5 vs 0.6 %, OR 4.02, p = 0.02), length of initial hospital stay>7 days (59.5 vs 42.5 %, OR 1.57, p = 0.01), and ICU admissions (11.6 vs 3.4 %, OR 2.90, p = 0.0005) were independently associated with readmissions. There were no postoperative biochemical variables that were predictive of readmissions. Fifty percent (n = 87) of the readmissions occurred within 7 days from initial operative discharge. The reasons for immediate (≤7 days) and nonimmediate (>7 days) readmissions differed; ileus, delayed gastric emptying, and pneumonia were more common in early readmissions, whereas wound infection, failure to thrive, and intra-abdominal hemorrhage were associated with late readmissions. The incidences of readmissions due to pancreatic fistulas and intra-abdominal abscesses were equally distributed between both time frames. The frequency of readmission after PD is 15 % and has been on the uptrend over the last decade.
Question:
Understanding hospital readmissions after pancreaticoduodenectomy: can we prevent them?
[/INST]

Generated Answer: Readmissions after PD occur frequently enough to warrant attention. Prospective studies are needed to determine whether specific patient or procedure characteristics could be used to identify high-risk patients and improve outcomes. This study suggests that the timing of readmissions may also provide valuable insights into how to optimize care after PD. Patients should be closely monitored after discharge and any readmission should be promptly addressed. Future work will need to focus on developing strategies to reduce readmissions after PD. Ultimately, this will require an integrated approach involving surgeons, primary care physicians, and other specialists. It may also involve changes in hospital policies and practices, such as improved discharge planning and better communication between providers. In addition, new technologies and devices are being developed to help identify patients at risk of complication and optimize their care. Although these interventions may not eliminate all readmissions after PD, they may reduce their number and impact. As such, it is important to understand why some patients do well after PD while others experience complications and readmission. By answering this question, we can develop novel strategies to improve outcomes and decrease readmissions after PD. Such efforts will ultimately lead to better patient outcomes, lower health-care costs, and greater efficiency in resource utilization. For example, if we could prevent only one readmission per year after PD by using a novel technology or device, it would translate into a cost savings of $15,000 to $30,000 per patient and potentially save millions of dollars annually. These savings could then be reinvested in research and development to further improve patient care and outcomes. In summary, understanding readmissions after PD is critical because it allows us to identify high-risk patients, intervene accordingly, and develop new strategies to improve outcomes and reduce costs. Although much work remains ahead, we hope that this study will serve as a starting point for future investigations into readmissions after PD.

Provided Answer: The complexity of initial resection and pancreatic fistula were independently associated with hospital readmissions after PD. Further efforts should be centered on preventing early readmissions, which constitute half of all readmissions. 

correctness: 0.3
Reasoning:
Explanation: The assistant's reply is generic and largely speculative. It fails to state the study's specific, factual findings — namely that pancreatic fistula and complexity of the initial resection (multivisceral resection) were independently associated with readmission (plus other independent factors such as LOS>7 days and ICU admission), and that about 50% of readmissions occur within 7 days (so preventing early readmissions should be a priority). Instead it offers broad recommendations and an unsupported cost estimate. Because it omits the key results and main actionable conclusion from the study, its factual usefulness is limited.

conciseness: 0.2
Reasoning:
Explanation: The assistant's reply is verbose and repetitive and therefore not concise. It gives broad, generic recommendations (closer monitoring, better discharge planning, integrated care, new technologies) but fails to succinctly state the study's key, actionable findings (pancreatic fistula and complex/multivisceral resection independently predict readmission; ~50% of readmissions occur within 7 days, so preventing early readmissions should be prioritized). Because the response is long-winded and omits the central study results, it scores poorly on conciseness.

relevance: 0.2
Reasoning:
The assistant's reply gives a plausible, general discussion of strategies to reduce readmissions after PD (closer monitoring, multidisciplinary care, better discharge planning, new technologies), but it fails to cite or explicitly reference the study's key findings. It does not mention that pancreatic fistula and complexity of the initial resection were independently associated with readmission, nor that about 50% of readmissions occur within 7 days and thus early readmissions warrant focused prevention — omissions that reduce relevance to the specific context and question.

coherence: 0.6
Reasoning:
The response is overall coherent and organized: it states the problem, recommends closer postdischarge monitoring, multidisciplinary coordination, improved discharge planning, and development of risk‑stratification tools. However, it is generic and does not incorporate the study's key, specific findings (for example, that pancreatic fistula and the complexity of initial resection/multivisceral resection were independently associated with readmission, or that ~50% of readmissions occurred within 7 days with different early vs late causes). It offers few concrete, evidence‑linked prevention strategies and includes an unsupported cost‑saving example. In sum, the answer is clear and readable but insufficiently specific or evidence‑driven relative to the presented data.

helpfulness: 0.4
Reasoning:
The assistant's reply is broadly helpful but too generic and omits the study's key findings: it fails to mention that pancreatic fistula and complex/multivisceral resections (and related factors like prolonged initial stay and ICU admission) were independently associated with readmission, and it does not highlight that ~50% of readmissions occur within 7 days—so efforts should target early postdischarge care. The answer offers reasonable general strategies (closer monitoring, better discharge planning, multidisciplinary coordination) but lacks specific, evidence-linked recommendations or prioritization based on the data.

================================================================================
Average correctness Score: 0.405
Average conciseness Score: 0.33
Average relevance Score: 0.42
Average coherence Score: 0.48
Average helpfulness Score: 0.395
